Paradigm Capital Management (Nevada)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $953K | Sell |
39,295
-21,686
| -36% | -$526K | 0.94% | 30 |
|
|
2025
Q1 | $1.55M | Sell |
60,981
-25,097
| -29% | -$636K | 1.58% | 20 |
|
|
2024
Q4 | $2.28M | Sell |
86,078
-6,564
| -7% | -$174K | 2.13% | 12 |
|
|
2024
Q3 | $2.68M | Buy |
+92,642
| New | +$2.68M | 2.57% | 9 |
|
|
2022
Q4 | $2.82M | Buy |
55,038
+1,183
| +2% | +$60.6K | 4.13% | 6 |
|
|
2022
Q3 | $2.36M | Buy |
53,855
+135
| +0.3% | +$5.91K | 3.14% | 7 |
|
|
2022
Q2 | $2.82M | Sell |
53,720
-287
| -0.5% | -$15.1K | 3.54% | 7 |
|
|
2022
Q1 | $2.8M | Buy |
54,007
+304
| +0.6% | +$15.7K | 2.82% | 9 |
|
|
2021
Q4 | $3.17M | Buy |
+53,703
| New | +$3.17M | 3.15% | 8 |
|